[HTML][HTML] Genetic alterations defining NSCLC subtypes and their therapeutic implications

LA Pikor, VR Ramnarine, S Lam, WL Lam - Lung cancer, 2013 - Elsevier
Lung cancer is the leading cause of cancer death worldwide, accounting for more deaths
than breast, prostate and colon cancer combined. While treatment decisions are determined …

Molecular biology of lung cancer: clinical implications

JE Larsen, JD Minna - Clinics in chest medicine, 2011 - chestmed.theclinics.com
Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …

[HTML][HTML] Familial risk for lung cancer

M Kanwal, XJ Ding, Y Cao - Oncology letters, 2017 - … .spandidos-publications.com
Lung cancer, which has a low survival rate, is a leading cause of cancer-associated mortality
worldwide. Smoking and air pollution are the major causes of lung cancer; however …

A major lung cancer susceptibility locus maps to chromosome 6q23–25

JE Bailey-Wilson, CI Amos, SM Pinney… - The American Journal of …, 2004 - cell.com
Lung cancer is a major cause of death in the United States and other countries. The risk of
lung cancer is greatly increased by cigarette smoking and by certain occupational …

High-resolution genomic profiles of human lung cancer

G Tonon, KK Wong, G Maulik… - Proceedings of the …, 2005 - National Acad Sciences
Lung cancer is the leading cause of cancer mortality worldwide, yet there exists a limited
view of the genetic lesions driving this disease. In this study, an integrated high-resolution …

Karyotypic complexity of the NCI-60 drug-screening panel

AV Roschke, G Tonon, KS Gehlhaus, N McTyre… - Cancer research, 2003 - AACR
We used spectral karyotyping to provide a detailed analysis of karyotypic aberrations in the
diverse group of cancer cell lines established by the National Cancer Institute for the …

[HTML][HTML] Genetic changes in squamous cell lung cancer: a review

RS Heist, LV Sequist, JA Engelman - Journal of thoracic oncology, 2012 - Elsevier
Identifying specific somatic mutations that drive tumor growth has transformed the treatment
of lung cancer. For example, cancers with sensitizing epidermal growth factor receptor …

Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis

M Rodriguez-Paredes, A Martinez de Paz… - Oncogene, 2014 - nature.com
Disruption of the histone modification patterns is one of the most common features of human
tumors. However, few genetic alterations in the histone modifier genes have been described …

Annexin A2: its molecular regulation and cellular expression in cancer development

CY Wang, CF Lin - Disease markers, 2014 - Wiley Online Library
Annexin A2 (ANXA2) orchestrates multiple biologic processes and clinical associations,
especially in cancer progression. The structure of ANXA2 affects its cellular localization and …

[HTML][HTML] MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort

M Beau-Faller, AM Ruppert, AC Voegeli… - Journal of Thoracic …, 2008 - Elsevier
Introduction Recent clinical success of epidermal growth factor (EGFR)-tyrosine kinase
inhibitors (TKIs) in non-small cell lung cancer (NSCLC) have raised hopes that targeting …